The Global Fertility Testing Market to grow from USD 255.35 Million in 2019 to USD 401.40 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 7.82%.
Market Segmentation & Coverage:
The research report categorizes the Fertility Testing Market to forecast the revenues and analyze the trends in each of the following segments:
Based on Product, the Fertility Testing Market studied across Fertility Monitoring Devices, Male Fertility Testing Products, and Ovulation Predictor Kits. The Fertility Monitoring Devices further studied across Saliva-Based Monitor and Urine-Based Monitor.
Based on Mode of Purchase, the Fertility Testing Market studied across Non-Prescription/OTC-Based, Online, and Prescription-Based.
Based on Application, the Fertility Testing Market studied across Female Fertility Testing and Male Fertility Testing.
Based on End User, the Fertility Testing Market studied across Homecare Settings, Hospitals, and Specialty Clinics & Fertility Center.
Based on Geography, the Fertility Testing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
The factors attributing to the growth of the market are introduction of advanced and easy-to-use fertility monitors with high accuracy, awareness about fertility testing, and declining fertility rates across the globe. However, some factors such as lesser precision to confirm ovulation and high price associated with ovulation monitors may hinder the market growth. The Fertility Testing Market expected to showcase the opportunities such as sperm testing at home and combined test kit for testing of pregnancy and ovulation. Soon market may face the possible challenges in the growth due to malfunctioning of urine-based ovulation monitors in pcos/pcod patients. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.
Global Fertility Testing Market: Market Dynamics
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Fertility Testing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Company Usability Profiles:
The Fertility Testing Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Fertility Testing Market, including AccuQuik, Advacare Pharma, Alere Inc., AVA, Babystart, Biozhena, Church & Dwight Co., Inc, Fairhaven Health LLC, Fertility Focus, Geratherm Medical AG, Hilin Life Products, Prestige Brands Holdings, Inc., Quidel Corporation, Sensiia, SPD Swiss Precision Diagnostics GmbH, Swiss Precision Diagnostics, Taidoc, Uebe Medical, and Valley Electronics.